Marathon Petroleum (MPC) Forms $74.88 Double Top; Varian Medical Systems Has 0.67 Sentiment

Varian Medical Systems, Inc. (NYSE:VAR) Logo

Marathon Petroleum Corporation (MPC) formed double top with $80.12 target or 7.00% above today’s $74.88 share price. Marathon Petroleum Corporation (MPC) has $34.59 billion valuation. The stock decreased 0.77% or $0.58 during the last trading session, reaching $74.88. About 4.65 million shares traded. Marathon Petroleum Corporation (NYSE:MPC) has risen 46.81% since June 14, 2017 and is uptrending. It has outperformed by 34.24% the S&P500. Some Historical MPC News: ; 30/04/2018 – MARATHON PETROLEUM & ANDEAVOR TO COMBINE; 30/04/2018 – Correct: Marathon Petroleum 1Q Rev $18.98B; 30/04/2018 – MARATHON PETROLEUM CONFIRMS DEAL TO BUY ANDEAVOR; 30/04/2018 – MARATHON PETROLEUM 1Q REV. $18.98B, EST. $20.46B; 24/05/2018 – SOUTH AFRICA’S RAND ZAR=D3 STEADY AT 12.41 AGAINST DOLLAR AFTER CENTRAL BANK GOVERNOR BEGINS READING MPC STATEMENT; 13/03/2018 – SARB EXPECTS VAT EFFECT ON INFLATION TO BE “ONE OFF”, WOULD NOT REACT BY RAISING RATES -MPC MEMBER; 28/03/2018 – S. AFRICA’S KGANYAGO: MPC SEES RISK TO GROWTH OUTLOOK ON UPSIDE; 10/04/2018 – Marathon Petroleum Corp. earns 2018 ENERGY STAR® Partner of the Year Award; 30/04/2018 – MPC BOARD APPROVED AN INCREMENTAL $5B OF BUYBACK AUTHORIZATION; 05/04/2018 – INDIA CENBANK CHIEF PATEL:MPC NOTED SEVERAL UNCERTAINTIES AROUND BASELINE INFLATION PATH

Varian Medical Systems Inc (VAR) investors sentiment decreased to 0.67 in 2018 Q1. It’s down -0.13, from 0.8 in 2017Q4. The ratio fall, as 167 investment professionals increased and started new holdings, while 248 reduced and sold positions in Varian Medical Systems Inc. The investment professionals in our database now own: 82.38 million shares, down from 87.00 million shares in 2017Q4. Also, the number of investment professionals holding Varian Medical Systems Inc in top ten holdings increased from 1 to 2 for an increase of 1. Sold All: 34 Reduced: 214 Increased: 109 New Position: 58.

Since January 1, 0001, it had 0 insider purchases, and 21 selling transactions for $22.36 million activity.

The stock increased 0.50% or $0.61 during the last trading session, reaching $122.95. About 351,648 shares traded. Varian Medical Systems, Inc. (VAR) has risen 21.31% since June 14, 2017 and is uptrending. It has outperformed by 8.74% the S&P500. Some Historical VAR News: ; 22/05/2018 – SRX SIRTEX RESPONDS TO VARIAN RELEASE ON CDH COMPETING BID; 23/04/2018 – Varex Imaging Names Rosebrough To Board Of Directors; 22/05/2018 – SIRTEX MEDICAL LTD SRX.AX – BOARD CONSIDERING RELATIVE MERITS AND RISKS OF CDH PROPOSAL AND VARIAN MEDICAL SYSTEMS SCHEME; 16/05/2018 – First Cancer Patients in Korea Treated with Varian HyperArc High-Definition Radiotherapy; 26/03/2018 – SIRTEX REPORTS FIRB APPROVAL ON VARIAN SCHEME OF ARRANGEMENT; 25/04/2018 – VARIAN MEDICAL SYSTEMS INC SEES FY18 REVENUE GROWTH RANGE OF 6 PERCENT TO 9 PERCENT, WHICH NOW INCLUDES IMPACT FROM CURRENCY FOR REMAINDER OF YEAR; 26/04/2018 – Hospital Alemão Oswaldo Cruz in Brazil Selects Varian Halcyon Cancer Treatment System; 22/05/2018 – VARIAN MEDICAL SYSTEMS INC VAR.N – VARIAN NOTIFIES SIRTEX IT WILL NOT SUBMIT A COUNTERPROPOSAL TO COMPETING BID; 22/05/2018 – Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid; 07/05/2018 – Varian Acquires Taiwan Distributor

More recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: which released: “Varian Announces Third Quarter Fiscal Year 2018 Earnings Release Date” on June 11, 2018. Also published the news titled: “Varian Medical Systems (VAR) Deal to Close Sirtex Medical Deal Delayed Following Australian Court Denial – RBCc” on May 29, 2018.‘s news article titled: “Varian to Demonstrate Advanced Brachytherapy Solutions at ABS 2018” with publication date: June 05, 2018 was also an interesting one.

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $11.25 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 92.37 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Ratings analysis reveals 50% of Varian Medical’s analysts are positive. Out of 2 Wall Street analysts rating Varian Medical, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $93.0 while the high is $98.0. The stock’s average target of $95.50 is -22.33% below today’s ($122.95) share price. VAR was included in 2 notes of analysts from January 23, 2017. On Monday, January 23 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The rating was maintained by Barrington Research with “Outperform” on Friday, January 27.

Capital Counsel Llc Ny holds 3.12% of its portfolio in Varian Medical Systems, Inc. for 314,372 shares. Saratoga Research & Investment Management owns 318,725 shares or 2.86% of their US portfolio. Moreover, Fairpointe Capital Llc has 2.58% invested in the company for 1.01 million shares. The Illinois-based Oakbrook Investments Llc has invested 2.46% in the stock. Jlb & Associates Inc, a Michigan-based fund reported 81,083 shares.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on July, 25. They expect $1.00 EPS, down 3.85% or $0.04 from last year’s $1.04 per share. VAR’s profit will be $91.51M for 30.74 P/E if the $1.00 EPS becomes a reality. After $1.15 actual EPS reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -13.04% negative EPS growth.

Since March 6, 2018, it had 1 buying transaction, and 2 selling transactions for $3.27 million activity. Another trade for 24,818 shares valued at $1.97M was made by Kelley Thomas M. on Wednesday, May 30. BUNCH CHARLES E bought 1,500 shares worth $101,070.

Analysts await Marathon Petroleum Corporation (NYSE:MPC) to report earnings on July, 26. They expect $1.71 EPS, up 66.02% or $0.68 from last year’s $1.03 per share. MPC’s profit will be $789.80M for 10.95 P/E if the $1.71 EPS becomes a reality. After $0.08 actual EPS reported by Marathon Petroleum Corporation for the previous quarter, Wall Street now forecasts 2,037.50% EPS growth.

Marathon Petroleum Corporation (NYSE:MPC) Institutional Positions Chart